Recombinant Anti-CD33 × Anti-DENV Bispecific Antibody (CrossMab) (CAT#: CROSS-L009)
Recombinant Anti-CD33 × Anti-denguevirus Bispecific Antibody (CrossMab) has been generated by applying the Crossmab format to generate an IgGshaped entity that binds each ligand with one arm is capable of subneutralizing concentrations enhance dengue virus infection of Fc gamma R+ cells. It was designed for the treatment of enhanced dengue virus infection.
Specific Inquiry
Specifications
- Target
- CD33 & DENV
- Type
- CrossMab
- Species Reactivity
- Human
- Target 1
- CD33
- Host Species 1
- Mouse
- Target 2
- DENV
- Host Species 2
- Mouse
- Application
- FuncS, Promising therapeutic agent
Target
- Target 1
- CD33
- Gene ID
- 945
- UniProt ID
- P20138
- Alternative Names
- CD33; CD33 molecule; p67; SIGLEC3; SIGLEC-3; myeloid cell surface antigen CD33; gp67; CD33 antigen (gp67); sialic acid binding Ig-like lectin 3; sialic acid-binding Ig-like lectin 3
- Target 2
- DENV
- Alternative Names
- dengue virus; DENV; dengue fever; Flavivirus
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
Customer Reviews and Q&As
There are currently no Customer reviews or questions for CROSS-L009. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
Send Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.